Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986

PURPOSE: There is no standard treatment for patients with advanced urothelial cancer who are ineligible (“unfit”) for cisplatin-based chemotherapy (CHT). To compare the activity and safety of two CHT combinations in this patient group, a randomized phase II/III trial was conducted by the EORTC (Euro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: De Santis, Maria, Bellmunt, Joaquim, Mead, Graham, Kerst, J. Martijn, Leahy, Michael, Maroto, Pablo, Skoneczna, Iwona, Marreaud, Sandrine, de Wit, Ronald, Sylvester, Richard
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2009
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2792956/
https://ncbi.nlm.nih.gov/pubmed/19786668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.21.4924
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky